Home Blood Transfusions

The study is a single arm pilot study to evaluate the implementation of a novel home blood transfusion program at Thomas Jefferson University Hospital. The study population will include patients with hematologic malignancies and other bone marrow failure syndromes with transfusion dependent cytopenias. Participants will receive home blood draws and if needed same day transfusions. Data will be collected via surveys at time of each study visit, participant surveys at the end of the intervention as well as a semi structured interview. Each participant in the study will receive 1-2 blood products transfused in the home each week for a total of 5 transfusions. As a result each participant will be eligible to receive transfusions at home for 5 weeks.

Inclusion criteria

• Individuals must meet all of the following inclusion criteria in order to be eligible to participate in the study:
• Provide signed and dated informed consent form Willing to comply with all study procedures and be available for the duration of the study
• Male or female, over the age of 18
• Must meet definition of transfusion dependence (require at least 2 blood product transfusions over a 28-day period)
• Receive their cancer care at SKCCC
• Have a history of blood product transfusions and NO history of transfusion reactions,
• Live within a 30-mile range of the Center City SKCCC location.
• Must be willing to allow people into the home

Exclusion criteria

• An individual who meets any of the following criteria will be excluded from participation in this study:
• Patients who have a history of a transfusion reaction
• Heart failure as defined by AHA stage C or NYHA Class II-IV
• Non-English or Spanish speaking
• Are unhoused
• Are incarcerated
• Have poor venous access
• Diagnosis of Solid Tumor malignancy
• Women who are pregnant